Mandate

VINGE ADVISES TOBII IN CONNECTION WITH THE LISTING ON NASDAQ STOCKHOLM

April 28, 2015

Vinge advises Tobii AB (publ) in connection with Tobii’s listing on Nasdaq Stockholm.

Tobii is the global leader in eye tracking, a technology that is used to gain insights in human behavior or as a means to interact with computers and other devices. The Swedish language prospectus was published on 13 April 2015 and the first day of trading was 24 April 2015. The offering price has been set at SEK 25 per share, corresponding to a market value of Tobii of approximately SEK 2.1 billion.

Vinge’s team primarily consisted of Jesper Schönbeck, Johan Winnerblad, Rikard Lindahl, Charlotta Järnstedt and Henrik Wastenson.

Related

Vinge has advised Accent Equity VI and the minority shareholders on their divestment of Malte Månson

Vinge has advised Accent Equity VI and the minority shareholders on their divestment of Malte Månson to Citira, a European tire management provider and portfolio company of Norvestor. Headquartered in Stockholm, Malte Månson is an independent service and repair provider for commercial vehicles and operates a network of 28 service workshop locations across Sweden, authorized by brands such as MAN, DAF, IVECO, Mercedes-Benz, Setra, VDL and EVO. Malte Månson has an annual revenue of SEK 800 million and employs over 300 full-time professionals.
June 08, 2026

Vinge advises InArea on entering into a SEK 450 million credit agreement with SEB

InArea's new facilities agreement comprises a term loan and a revolving credit facility, replacing the company's existing facilities. The facilities agreement also includes an option to increase the lending framework through an incremental facility of up to SEK 200 million.
June 03, 2026

Vinge has advised the arrangers in connection with St1 Biokraft’s EUR 260 million financing

Vinge has advised the arrangers, ING Bank N.V., ABN AMRO Bank N.V., DNB Bank ASA, Nordea Bank Abp, OP Corporate Bank plc, Coöperatieve Rabobank U.A., SpareBank 1 Sør-Norge ASA and Swedbank AB, in connection with St1 Biokraft AB’s EUR 260 million financing.
June 03, 2026